Home  |  Contact

ProtParam

User-provided sequence:

        10         20         30         40         50         60 
MAQQAADKYL YVDKNFINNP LAQADWAAKK LVWVPSDKSG FEPASLKEEV GEEAIVELVE

70 80 90 100 110 120
NGKKVKVNKD DIQKMNPPKF SKVEDMAELT CLNEASVLHN LKERYYSGLI YTYSGLFCVV

130 140 150 160 170 180
INPYKNLPIY SEEIVEMYKG KKRHEMPPHI YAITDTAYRS MMQDREDQSI LCTGESGAGK

190 200 210 220 230 240
TENTKKVIQY LAYVASSHKS KKDQGELERQ LLQANPILEA FGNAKTVKND NSSRFGKFIR

250 260 270 280 290 300
INFDVNGYIV GANIETYLLE KSRAIRQAKE ERTFHIFYYL LSGAGEHLKT DLLLEPYNKY

310 320 330 340 350 360
RFLSNGHVTI PGQQDKDMFQ ETMEAMRIMG IPEEEQMGLL RVISGVLQLG NIVFKKERNT

370 380 390 400 410 420
DQASMPDNTA AQKVSHLLGI NVTDFTRGIL TPRIKVGRDY VQKAQTKEQA DFAIEALAKA

430 440 450 460 470 480
TYERMFRWLV LRINKALDKT KRQGASFIGI LDIAGFEIFD LNSFEQLCIN YTNEKLQQLF

490 500 510 520 530 540
NHTMFILEQE EYQREGIEWN FIDFGLDLQP CIDLIEKPAG PPGILALLDE ECWFPKATDK

550 560 570 580 590 600
SFVEKVMQEQ GTHPKFQKPK QLKDKADFCI IHYAGKVDYK ADEWLMKNMD PLNDNIATLL

610 620 630 640 650 660
HQSSDKFVSE LWKDVDRIIG LDQVAGMSET ALPGAFKTRK GMFRTVGQLY KEQLAKLMAT

670 680 690 700 710 720
LRNTNPNFVR CIIPNHEKKA GKLDPHLVLD QLRCNGVLEG IRICRQGFPN RVVFQEFRQR

730 740 750 760 770 780
YEILTPNSIP KGFMDGKQAC VLMIKALELD SNLYRIGQSK VFFRAGVLAH LEEERDLKIT

790 800 810 820 830 840
DVIIGFQACC RGYLARKAFA KRQQQLTAMK VLQRNCAAYL KLRNWQWWRL FTKVKPLLQV

850 860 870 880 890 900
SRQEEEMMAK EEELVKVREK QLAAENRLTE METLQSQLMA EKLQLQEQLQ AETELCAEAE

910 920 930 940 950 960
ELRARLTAKK QELEEICHDL EARVEEEEER CQHLQAEKKK MQQNIQELEE QLEEEESARQ

970 980 990 1000 1010 1020
KLQLEKVTTE AKLKKLEEEQ IILEDQNCKL AKEKKLLEDR IAEFTTNLTE EEEKSKSLAK

1030 1040 1050 1060 1070 1080
LKNKHEAMIT DLEERLRREE KQRQELEKTR RKLEGDSTDL SDQIAELQAQ IAELKMQLAK

1090 1100 1110 1120 1130 1140
KEEELQAALA RVEEEAAQKN MALKKIRELE SQISELQEDL ESERASRNKA EKQKRDLGEE

1150 1160 1170 1180 1190 1200
LEALKTELED TLDSTAAQQE LRSKREQEVN ILKKTLEEEA KTHEAQIQEM RQKHSQAVEE

1210 1220 1230 1240 1250 1260
LAEQLEQTKR VKANLEKAKQ TLENERGELA NEVKVLLQGK GDSEHKRKKV EAQLQELQVK

1270 1280 1290 1300 1310 1320
FNEGERVRTE LADKVTKLQV ELDNVTGLLS QSDSKSSKLT KDFSALESQL QDTQELLQEE

1330
NRQKLSLSTK LKQVEDE


References and documentation are available.

Number of amino acids: 1337 Molecular weight: 154362.36 Theoretical pI: 5.70
Amino acid composition: 
Ala (A) 102 7.6% Arg (R) 71 5.3% Asn (N) 57 4.3% Asp (D) 63 4.7% Cys (C) 18 1.3% Gln (Q) 101 7.6% Glu (E) 166 12.4% Gly (G) 56 4.2% His (H) 21 1.6% Ile (I) 67 5.0% Leu (L) 154 11.5% Lys (K) 134 10.0% Met (M) 33 2.5% Phe (F) 44 3.3% Pro (P) 31 2.3% Ser (S) 56 4.2% Thr (T) 60 4.5% Trp (W) 10 0.7% Tyr (Y) 30 2.2% Val (V) 63 4.7% Pyl (O) 0 0.0% Sec (U) 0 0.0% (B) 0 0.0% (Z) 0 0.0% (X) 0 0.0%
Total number of negatively charged residues (Asp + Glu): 229 Total number of positively charged residues (Arg + Lys): 205 Atomic composition: Carbon C 6788 Hydrogen H 10982 Nitrogen N 1894 Oxygen O 2100 Sulfur S 51 Formula: C6788H10982N1894O2100S51 Total number of atoms: 21815 Extinction coefficients: Extinction coefficients are in units of M-1 cm-1, at 280 nm measured in water. Ext. coefficient 100825 Abs 0.1% (=1 g/l) 0.653, assuming all pairs of Cys residues form cystines Ext. coefficient 99700 Abs 0.1% (=1 g/l) 0.646, assuming all Cys residues are reduced Estimated half-life: The N-terminal of the sequence considered is M (Met). The estimated half-life is: 30 hours (mammalian reticulocytes, in vitro). >20 hours (yeast, in vivo). >10 hours (Escherichia coli, in vivo). Instability index: The instability index (II) is computed to be 48.33 This classifies the protein as unstable. Aliphatic index: 85.76 Grand average of hydropathicity (GRAVY): -0.677